- KR₩966bn
- KR₩1tn
- KR₩1tn
Brief: Hk Inno.N Corp To Invest 97 Billion Won In New Production Facilities
Brief: Hk Inno.N Q1 Operating Profit 33.2 Billion Won, Up 31% From Year Earlier
Brief: Hk Inno.N Q3 Operating Profit 26 Billion Won, Up 16.4% From Year Earlier
Brief: Hk Inno.N Q2 Operating Profit 19.5 Billion Won, Down 20% From Year Earlier
Brief: Hk Inno.N Q1 Operating Profit 25.4 Billion Won, Up 47% From Year Earlier
Brief: Hk Inno.N Corp Q4 Operating Profit 24.4 Billion Won, Up 8.2% From Year Earlier
Brief: Hk Inno.N Corp Q3 Operating Profit 22 Billion Won, Down 1% From Year Earlier
Brief: Hk Inno.N Corp Q2 Operating Profit 24.3 Billion Won, Up 59% From Year Earlier
Brief: Hk Inno.N Corp Q1 Operating Profit 17.3 Billion Won, Up 206% From Year Earlier
Brief: Hk Inno.N Q4 Operating Profit 22.5 Billion Won, Up 169% From Year Earlier
Brief: Hk Inno.N Q3 Operating Profit 22.4 Billion Won, Up 0.7% From Year Earlier
Brief: Hk Inno.N Corp Q2 Operating Profit 15.3 Billion Won, Down 13% From Year Earlier
Brief: Hk Innon Corp Q1 Operating Profit 5.6 Billion Won, Up 33% From Year Earlier
Brief: Hk Innon Corp To Cancel 24 Billion Won Worth Of Own Shares
Brief: Hk Innon Corp Q3 Operating Profit 22 Billion Won, Up 30% From Year Earlier
Brief: Sebela Pharmaceuticals Acquires Exclusive Licensing Rights To Develop And Commercialize Tegoprazan In U.S. And Canada
Brief: HK Inno.N Corp Q2 Operating Profit 18 Billion Won, Up 497% From Year Earlier